Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/20/2026

1. MRNA
2. KEYS
3. MRK
4. TGT
5. KLAR
6. SPY
7. PANW
8. LOW
9. UBER
10. HD

Go back to Sanofi Announces that First LixiLan Phase III Study Met Primary Endpoint
BANCO SANTANDER S.A. (NYSE: SAN) Delayed: 14.17 --0 (-0%)
Previous Close $14.17    52 Week High $5.58 
Open $14.17    52 Week Low $3.60 
Day High $14.17    P/E N/A 
Day Low $14.17    EPS $0.00 
Volume 256,289       

SANOFI (NASDAQ: SNY) Delayed: 45.83 --0 (-0%)
Previous Close $45.83    52 Week High $44.76 
Open $45.83    52 Week Low $36.81 
Day High $45.83    P/E N/A 
Day Low $45.83    EPS $0.00 
Volume 6,730       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(NASDAQ: ZEAL) Delayed: 17.59 --0 (-0%)
Previous Close $17.59    52 Week High $ 
Open $1.35    52 Week Low $ 
Day High $17.59    P/E N/A 
Day Low $17.59    EPS $ 
Volume 15,962       

(AMEX: ZLDPY) Delayed: 9.31 --0 (-0%)
Previous Close $9.31    52 Week High $ 
Open $9.31    52 Week Low $ 
Day High $9.31    P/E N/A 
Day Low $9.31    EPS $ 
Volume 5,603,641